NLRP3 and obstructive sleep apnea syndrome: This study identified the effects of rapamycin on OSA-associated renal injury. Inhibiting the mTOR signaling pathway by rapamycin can significantly reduce the levels of NLRP3 and organ damage caused by OSA.